Nesher, G, Margalit, R, Ashkenazi, Y J · Seminars in arthritis and rheumatism · 2001 · DOI
Quick Summary
This study looked at antibodies (immune proteins) that attack the nuclear envelope, the protective membrane around cell nuclei. Researchers found that different types of these antibodies are associated with different diseases, and preliminary findings suggest they may help diagnose ME/CFS. The study suggests that testing for these antibodies could help doctors identify certain autoimmune conditions.
Why It Matters
This research is significant for ME/CFS because it presents preliminary evidence that antilamin antibodies could serve as a diagnostic biomarker for the condition. As ME/CFS lacks objective diagnostic tests, identifying specific autoantibody patterns could help clinicians recognize the disease earlier and more reliably. Understanding immune abnormalities in ME/CFS may also help distinguish it from other autoimmune conditions with overlapping symptoms.
Observed Findings
Anti-gp210 and p62 antibodies show >95% specificity for primary biliary cirrhosis.
Antilamin antibodies associate with lupus anticoagulant, anticardiolipin antibodies, and antiphospholipid syndrome.
Antilamin antibodies are not disease-specific but show clinical associations with multiple autoimmune conditions.
Preliminary evidence suggests antilamin antibodies may be diagnostic for chronic fatigue syndrome.
Inferred Conclusions
Each anti-nuclear envelope antibody has a distinct disease association spectrum with diagnostic and prognostic value.
Indirect immunofluorescence detection of anti-nuclear envelope patterns, followed by specific antibody identification, could improve diagnosis of various autoimmune conditions.
Antilamin antibodies may represent a biomarker for stratifying disease subsets in conditions like lupus with prognostic implications.
Remaining Questions
What is the prevalence and clinical specificity of antilamin antibodies in well-characterized ME/CFS cohorts?
Do anti-nuclear envelope antibodies directly contribute to ME/CFS pathogenesis or represent an epiphenomenon of immune dysregulation?
What This Study Does Not Prove
This review does not establish causation between antilamin antibodies and ME/CFS symptoms, only an association. The 'preliminary data' mentioned for ME/CFS are not fully detailed in the abstract, making it unclear how robust or replicated these findings are. The study also does not demonstrate that anti-nuclear envelope antibodies are specific to ME/CFS or explain the biological mechanisms by which these antibodies might contribute to disease pathology.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.